Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Anne Laprie, Franck Desmoulin et al.|Magnetic Resonance in Medicine|2021Cited by 9
Prise en charge thérapeutique des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaisesM.‐T. Leccia, V. Mazeau-Woynar, François Planchamp et al.|Annales de Dermatologie et de Vénéréologie|2014Cited by 6
Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)Camille Verry, Jacques Balosso, Gerardo Villa et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 2
Traitements locorégionaux de métastase(s) cérébrale(s) chez des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaisesV. Lubrano, M.‐T. Leccia, Stéphane Derrey et al.|Neurochirurgie|2014Cited by 1
PO-0957 Radiomics study from the dose-painting multicenter phase III trial on newly diagnosed glioblastomaFatima Tensaouti, Anne Laprie, Julie Desrousseaux et al.|Radiotherapy and Oncology|2019Cited by 1